Dr. Olena Weaver

Claim this profile

M D Anderson Cancer Center

Studies Breast Cancer
5 reported clinical trials
7 drugs studied

Affiliated Hospitals

Image of trial facility.
M D Anderson Cancer Center

Clinical Trials Olena Weaver is currently running

Image of trial facility.

Contrast-Enhanced Mammography

for Breast Cancer

This clinical trial evaluates the added role of contrast-enhanced mammography (CEM), as well as imaging and blood biomarkers, for predicting the presence or absence of high-grade ductal carcinoma in situ (DCIS) or invasive cancer on pathology. Screening mammography is the mainstay of population-wide early breast cancer detection, and mammography-detected cancers are usually of an earlier stage, giving women the best chance of survival. However, the main drawbacks of this type of screening are false positive results and potential over-diagnosis of breast cancer. Suspicious microcalcifications detected with mammography pose a particular diagnostic problem, as they may be associated with invasive and high-grade in-situ cancers like DCIS, but are more often benign or require further workup to verify diagnosis. As such, microcalcifications detected by mammography pose a risk of both over-diagnosis and underestimation of disease severity. This study evaluates the impact of using CEM, compared to standard full field digital mammography (FFDM) for the management of suspicious microcalcifications and prediction of breast cancer in women with this finding.
Recruiting1 award N/A3 criteria
Image of trial facility.

CESM

for Breast Cancer Detection

This clinical trial studies contrast enhanced spectral mammography (CESM) for the evaluation of pathologic nipple discharge. CESM is similar to standard mammography, but it includes an intravenous (by vein) injection of an iodine-based contrast, which makes tissue and blood vessels more visible in scans. The goal of this trial is to learn if CESM, is better than standard mammography in quickly and efficiently determining the cause of nipple discharge and detecting breast cancer, if present. CESM may increase the chance of finding breast cancers and lower the risk of having unnecessary biopsies.
Recruiting2 awards N/A3 criteria

More about Olena Weaver

Clinical Trial Related4 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Olena Weaver has experience with
  • Contrast-Enhanced Mammography
  • Iodinated Contrast Agent
  • Contrast Enhanced Digital Mammography
  • Digital Tomosynthesis Mammography
  • Biospecimen Collection
  • Contrast Agent

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Olena Weaver specialize in?
Is Olena Weaver currently recruiting for clinical trials?
Are there any treatments that Olena Weaver has studied deeply?
What is the best way to schedule an appointment with Olena Weaver?
What is the office address of Olena Weaver?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security